UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
6626
Neumora Therapeutics
NMRA
$94.6M
| $244K | ﹤0.01% |
143,725
+84,141
| +141% | +$160K |
2023 Q4
10 quarters
|
|
6627
Axiom Intelligence Acquisition Corp 1
AXIN
$284M
| $244K | ﹤0.01% |
23,600
+21,699
| +1,141% | +$223K |
2026 Q1
1 quarter
|
|
6628
Outlook Therapeutics
OTLK
$106M
| $242K | ﹤0.01% |
152,215
+19,146
| +14% | +$11.9K |
2023 Q4
10 quarters
|
|
6629
VanEck Retail ETF
RTH
$259M
| $242K | ﹤0.01% |
945
-435
| -32% | -$114K |
2014 Q4
46 quarters
|
|
6630
T-Rex 2X Long MSTR Daily Target ETF
MSTU
$525M
| $241K | ﹤0.01% |
14,903
-4,084
| -22% | -$224K |
2024 Q3
7 quarters
|
|
|
ENRD
6631
Einride AB American Depositary Shares
ENRD
$271M
| $241K | ﹤0.01% |
+27,891
| New | +$245K |
2026 Q2
0 quarters
|
|
6632
CALL
NEOS S&P 500 High Income ETF
SPYI
$12.2B
| $240K | ﹤0.01% |
+4,512
| New | +$237K |
2026 Q2
0 quarters
|
|
6633
Ceragon Networks
CRNT
$208M
| $239K | ﹤0.01% |
92,302
+15,302
| +20% | +$40K |
2021 Q2
20 quarters
|
|
6634
PUT
Allstate
ALL
$63.1B
| $238K | ﹤0.01% |
1,000
| – | – |
2025 Q1
5 quarters
|
|
6635
Hooker Furnishings Corp
HOFT
$155M
| $238K | ﹤0.01% |
13,339
-17,936
| -57% | -$245K |
2014 Q4
46 quarters
|
|
6636
DELISTED
KORE Group Holdings
KORE
| $237K | ﹤0.01% |
25,644
-118,937
| -82% | -$1.09M |
2021 Q4
18 quarters
|
|
6637
Nine Energy Service Inc
NINE
$104M
| $236K | ﹤0.01% |
+18,167
| New | +$184K |
2026 Q2
0 quarters
|
|
6638
Vivid Seats
SEAT
$23.5M
| $236K | ﹤0.01% |
36,224
-9,558
| -21% | -$73.3K |
2023 Q4
10 quarters
|
|
6639
DELISTED
GETTY IMAGES HLDGS INC A
GETY
| $236K | ﹤0.01% |
274,019
-22,248
| -8% | -$19.3K |
2024 Q2
8 quarters
|
|
6640
Meridian Holdings Inc
MRDN
$110M
| $235K | ﹤0.01% |
16,894
+2,427
| +17% | +$25.4K |
2023 Q3
11 quarters
|
|
6641
iShares Morningstar Multi-Asset Income ETF
IYLD
$129M
| $235K | ﹤0.01% |
10,612
+1,626
| +18% | +$36K |
2014 Q4
46 quarters
|
|
6642
KLX Energy Services
KLXE
$105M
| $235K | ﹤0.01% |
90,921
+76,556
| +533% | +$227K |
2023 Q2
12 quarters
|
|
6643
Minerva Neurosciences
NERV
$116M
| $234K | ﹤0.01% |
42,208
-25,362
| -38% | -$138K |
2023 Q2
12 quarters
|
|
6644
Invesco New York AMT-Free Municipal Bond ETF
PZT
$136M
| $234K | ﹤0.01% |
10,300
-23,975
| -70% | -$538K |
2014 Q4
46 quarters
|
|
6645
John Marshall Bancorp
JMSB
$327M
| $234K | ﹤0.01% |
10,735
-307
| -3% | -$6.51K |
2022 Q2
16 quarters
|
|
6646
Friedman Industries
FRD
$260M
| $234K | ﹤0.01% |
7,272
-889
| -11% | -$21K |
2022 Q4
14 quarters
|
|
6647
X Financial
XYF
$212M
| $233K | ﹤0.01% |
48,198
+4,141
| +9% | +$19.8K |
2024 Q3
7 quarters
|
|
6648
Whitehawk Therapeutics
WHWK
$178M
| $233K | ﹤0.01% |
50,841
+39,403
| +344% | +$164K |
2022 Q4
14 quarters
|
|
6649
Avantis Short-Term Fixed Income ETF
AVSF
$643M
| $233K | ﹤0.01% |
4,995
+4,932
| +7,829% | +$230K |
2026 Q1
1 quarter
|
|
6650
United Maritime
USEA
$22.6M
| $232K | ﹤0.01% |
88,396
+8,507
| +11% | +$20K |
2026 Q1
1 quarter
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,282 new, 4,216 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,282 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.